RAPT Therapeutics Inc’s filing revealed that its CHIEF SCIENTIFIC OFFICER Brockstedt Dirk G. unloaded Company’s shares for reported $20456.0 on Jan 05 ’24. In the deal valued at $22.78 per share,898 shares were sold. As a result of this transaction, Brockstedt Dirk G. now holds 27,820 shares worth roughly $0.12 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, HO WILLIAM sold 2,500 shares, generating $54,200 in total proceeds. Upon selling the shares at $21.68, the Chief Medical Officer now owns 15,020 shares.
Before that, HO WILLIAM sold 1,500 shares. RAPT Therapeutics Inc shares valued at $20,580 were divested by the Chief Medical Officer at a price of $13.72 per share. As a result of the transaction, HO WILLIAM now holds 17,520 shares, worth roughly $73233.59999999999.
Wolfe Research downgraded its RAPT Therapeutics Inc [RAPT] rating to a Peer perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Guggenheim’s analysts, who decreased its forecast for the stock in early May from “a Buy” to “a Neutral”. Barclays also remained covering RAPT and has decreased its forecast on May 10, 2024 with a “an Equal weight” recommendation from previously “an Overweight” rating. UBS revised its rating on February 22, 2024. It rated RAPT as “a Neutral” which previously was an “a Buy”.
Price Performance Review of RAPT
On Friday, RAPT Therapeutics Inc [NASDAQ:RAPT] saw its stock fall -6.80% to $4.18. Over the last five days, the stock has gained 3.47%. RAPT Therapeutics Inc shares have fallen nearly -83.18% since the year began. Nevertheless, the stocks have fallen -80.03% over the past one year. While a 52-week high of $27.35 was reached on 02/12/24, a 52-week low of $3.95 was recorded on 05/21/24. SMA at 50 days reached $7.35, while 200 days put it at $15.06. A total of 0.45 million shares were traded, compared to the trading of 0.51 million shares in the previous session.
Levels Of Support And Resistance For RAPT Stock
The 24-hour chart illustrates a support level at 4.00, which if violated will result in even more drops to 3.82. On the upside, there is a resistance level at 4.45. A further resistance level may holdings at 4.72. The Relative Strength Index (RSI) on the 14-day chart is 28.13, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.41, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 94.71%. Stochastics %K at 10.63% indicates the stock is a buying.
